BNTC
Benitec Biopharma Inc.
$13.44
+0.24 (+1.82%)
At close · Jul 7
Market Cap
$461.72M
Shares
34,354,334
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Megan Boston | member of the Board | Resigned | 2026-05-29 |
| David Friedman | director of the Board | Appointed | 2026-05-29 |